1043 related articles for article (PubMed ID: 14966565)
1. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.
Shimada T; Kakitani M; Yamazaki Y; Hasegawa H; Takeuchi Y; Fujita T; Fukumoto S; Tomizuka K; Yamashita T
J Clin Invest; 2004 Feb; 113(4):561-8. PubMed ID: 14966565
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.
Shimada T; Yamazaki Y; Takahashi M; Hasegawa H; Urakawa I; Oshima T; Ono K; Kakitani M; Tomizuka K; Fujita T; Fukumoto S; Yamashita T
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1088-95. PubMed ID: 15998839
[TBL] [Abstract][Full Text] [Related]
5. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.
Shimada T; Hasegawa H; Yamazaki Y; Muto T; Hino R; Takeuchi Y; Fujita T; Nakahara K; Fukumoto S; Yamashita T
J Bone Miner Res; 2004 Mar; 19(3):429-35. PubMed ID: 15040831
[TBL] [Abstract][Full Text] [Related]
6. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
7. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Wolf M; Koch TA; Bregman DB
J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108
[TBL] [Abstract][Full Text] [Related]
9. Normal FGF23 levels in adult idiopathic phosphate diabetes.
Laroche M; Boyer JF; Jahafar H; Allard J; Tack I
Calcif Tissue Int; 2009 Feb; 84(2):112-7. PubMed ID: 19148564
[TBL] [Abstract][Full Text] [Related]
10. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
11. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
Yu X; Sabbagh Y; Davis SI; Demay MB; White KE
Bone; 2005 Jun; 36(6):971-7. PubMed ID: 15869926
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
[TBL] [Abstract][Full Text] [Related]
13. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.
Schouten BJ; Hunt PJ; Livesey JH; Frampton CM; Soule SG
J Clin Endocrinol Metab; 2009 Jul; 94(7):2332-7. PubMed ID: 19366850
[TBL] [Abstract][Full Text] [Related]
14. The role of bone in phosphate metabolism.
Fukumoto S
Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
[TBL] [Abstract][Full Text] [Related]
15. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.
Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961
[TBL] [Abstract][Full Text] [Related]
16. Bone formation regulates circulating concentrations of fibroblast growth factor 23.
Samadfam R; Richard C; Nguyen-Yamamoto L; Bolivar I; Goltzman D
Endocrinology; 2009 Nov; 150(11):4835-45. PubMed ID: 19819968
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
[TBL] [Abstract][Full Text] [Related]
18. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.
Miyamoto K; Ito M; Kuwahata M; Kato S; Segawa H
Ther Apher Dial; 2005 Aug; 9(4):331-5. PubMed ID: 16076377
[TBL] [Abstract][Full Text] [Related]
20. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice.
Tomoe Y; Segawa H; Shiozawa K; Kaneko I; Tominaga R; Hanabusa E; Aranami F; Furutani J; Kuwahara S; Tatsumi S; Matsumoto M; Ito M; Miyamoto K
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1341-50. PubMed ID: 20357029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
